Jellert Gaublomme

This inventor holds 8 USPTO granted patents and 2 published patent applications and 2 EPO patents. Top assignees: Massachusetts Institute of Technology, The Broad Institute, Inc., Harvard College. Active years: 2020-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jellert Gaublomme. Retrieved from https://idiyas.com/inventor/jellert-gaublomme

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 8 (Patent Applications = 2)

% Patents Active = 100.0

EPO Patents = 2 (Patent Applications = 3)

Average Co-Inventor Count = 3.8

ph-index = 3

Forward Citations = 51(Granted Patents)

Location History:

Maasmechelen, BE (2021)
Cambridge, MA (US) (2020 - 2023)

Company Filing History:

7 out of 8,586

Massachusetts Institute of Technology

patents

6 out of 486

The Broad Institute, Inc.

The Brigham and Women's Hospital, Inc.

patents

5. 2 out of 16,025

University of California

patents

6. 1 out of 7

The Board Institute, Inc.

patents

7. 1 out of 834,513

Other

patents

where one patent can have more than one assignee

Years Active: 2020-2023

Loading Chart...

8 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11841371 - Proteomics and spatial patterning using antenna networks (2023-12-12),

2. 11427869 - T cell balance gene expression, compositions of matters and methods of use thereof (2022-08-30),

3. 11332736 - Methods and compositions for multiplexing single cell and single nuclei sequencing (2022-05-17),

4. 11214797 - Assays for massively combinatorial perturbation profiling and cellular circuit reconstruction (2022-01-04),

5. 11209440 - T cell balance gene expression, compositions of matters and methods of use thereof (2021-12-28),

6. 11092607 - Multiplex analysis of single cell constituents (2021-08-17),

7. 11072816 - Single-cell proteomic assay using aptamers (2021-07-27),

8. 10822587 - T cell balance gene expression, compositions of matters and methods of use thereof (2020-11-03),

Title: Innovator Spotlight: Jellert Gaublomme

Introduction:

Jellert Gaublomme is an accomplished inventor based in Cambridge, MA, with a remarkable portfolio of 8 patents. His groundbreaking work has significantly impacted the fields of proteomics and cellular interactions.

Latest Patents:

1. Proteomics and spatial patterning using antenna networks: Gaublomme's innovative approach involves utilizing DNA antennas conjugated to proteins to create antenna networks for spatial mapping of biomolecules. This method allows for the deciphering of biomolecular and cellular interaction networks at a whole new level, especially in single-cell applications.

2. T cell balance gene expression: Gaublomme's patent focuses on identifying the regulatory network that influences T cell balance, particularly in Th17 cell differentiation. The compositions and methods developed enable the manipulation of target genes to modulate T cell balance for therapeutic and diagnostic purposes.

Career Highlights:

Gaublomme has made significant contributions to the field while working at prestigious institutions such as the Massachusetts Institute of Technology and The Broad Institute. His expertise and passion for innovation have led to pioneering discoveries in proteomics and genetic engineering.

Collaborations:

Throughout his career, Gaublomme has collaborated with esteemed professionals in the industry. Notably, he has worked alongside Aviv Regev and Vijay K Kuchroo, leading experts in the fields of genomics and immunology. These collaborations have further enriched his research and patent portfolio.

Conclusion:

Jellert Gaublomme stands out as a visionary inventor who continues to push the boundaries of science and technology. His patents not only showcase his technical prowess but also reflect his commitment to advancing research in proteomics and T cell biology.

Profile summary based on public USPTO records.